Seven peptides are on the July 23-24, 2026 agenda for section 503A review: BPC-157, KPV, TB-500, and MOTS-C on July 23, and Emideltide (DSIP), Semax, and Epitalon on July 24
Most patients with pernicious anaemia require lifelong treatment, and maintaining consistent therapy prevents recurrence of potentially serious complications
Legitimizing these peptides for compounding doesn't require nearly the same degree of evidence as FDA drug approval, but the agency still has a "responsibility to ensure that there's some level of safety before they become widely available," explains Bernstein
Doctors recommend lipotropic injections thrice a week, but this varies based on the doctor, the clinic, and the injection constituents